Strengthening Capacity for Prostate Cancer Early Diagnosis in West Africa Amidst the COVID-19 Pandemic: A Realist Approach to Rethinking and Operationalizing the World Health Organization 2017 Guide to Cancer Early DiagnosisCOVID-19 팬데믹 속에서 서아프리카의 전립선암 조기 진단 역량 강화: 세계보건기구 2017 암 조기 진단 가이드를 재고하고 운영하기 위한 현실주의적 접근Article Published on 2022-05-102022-09-11 Journal: Annals of Global Health [Category] COVID19(2023년), SARS, 치료기술, [키워드] approach broader impact cancer diagnosis Capacity collapse concomitant increase COVID-19 COVID-19 crisis creation demographics Diagnosis diagnostic diagnostic services Early Cancer global public health global public health emergency guide Health Health Organization health systems Healthcare systems operationalization Patient Prostate cancer remained Research restoration Rethinking SARS-CoV-2 Structure the disease West WHO World Health Organization [DOI] 10.5334/aogh.3519 PMC 바로가기 [Article Type] Article
COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutantsCOVID-19 환자 혈청은 다양한 SARS-CoV-2 RBD 돌연변이에 대한 ACE2-RBD 결합을 덜 강력하게 억제합니다Article Published on 2022-05-032022-09-11 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] ACE2 ACE2 binding ACE2 receptor ACE2-RBD ACE2-RBD binding Affect Analysis analyzed antibody bead binding classical correlated COVID-19 patient COVID-19 patient serum disease severity displaying E484K E484K mutation examined extension IgG levels immune protection increasingly Infectious virus inhibit Interaction less Longevity mimicking multiplex Multiplex assay mutant NAbs neutralization test neutralization tests Neutralizing activity Neutralizing antibodies positively correlated proceed protective immunity RBD RBDs Receptor binding domain reduced SARS-CoV-2 SARS-CoV-2 RBD SARS-CoV-2 variant SARS-CoV-2 variants serological serum sample serum samples severity the RBD therapy vaccination variant variants variants of interest virus neutralization test VoC VOCs VOIs was reduced WHO wild-type [DOI] 10.1038/s41598-022-10987-2 PMC 바로가기 [Article Type] Article
Severe Acute Respiratory Syndrome Coronavirus 2 Viremia Is Associated With Coronavirus Disease 2019 Severity and Predicts Clinical Outcomes중증 급성 호흡기 증후군 코로나바이러스 2 바이러스혈증은 코로나바이러스 질병 2019 심각도와 연관되어 있으며 임상 결과를 예측합니다Observational Study Published on 2022-05-032022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), MERS, SARS, 바이오마커, 임상, 진단, 치료기술, [키워드] 19 outcome 2 RNAemia 2 viremia acute respiratory syndrome acute respiratory syndrome coronavirus Admission Antibody titers bloodstream Care clinical clinical outcomes Cohort coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 CoV COVID COVID-19 COVID-19 patient COVID-19 severity cross-sectional discharge disease severity electron tomography hazard ratio Health Organization Hospitalized Host immune response host immune responses ICU ICU Patients immune responses immunostaining indicate Inflammatory biomarker Inpatients Level Mortality Neutralizing antibody titer neutralizing antibody titers non-ICU outcome outcomes Outpatient outpatients Patient pellet plasma plasma sample plasma samples quantified reflect respiratory SARS SARS-CoV-2 severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 significantly significantly higher Viral Viral RNA Viremia virion virions virus particle virus particles Visualization vRNA WHO World Health Organization [DOI] 10.1093/cid/ciab686 PMC 바로가기 [Article Type] Observational Study
Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccinesSARS-CoV-2의 오미크론 변종: 유전체학, 전염성 및 현재 COVID-19 백신에 대한 반응Review Published on 2022-05-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Anxiety coronavirus COVID-19 vaccine disease disease control Effectiveness Efficacy Genomics Health Organization high risk higher risk immune immune responses in some Infection information management mutated mutated virus new strain omicron Omicron variant pandemic Preliminary data Reinfection response SARS Coronavirus SARS-CoV-2 severe acute respiratory syndrome Coronavirus Spread Transmissibility Transmission Treatment Vaccine Vaccines vaccines/vaccine strains variant variant of SARS-CoV-2 virus virus classification WHO World Health Organization [DOI] 10.1002/jmv.27588 PMC 바로가기 [Article Type] Review
Risk stratification and assessment framework for international travel and border measures amidst the COVID-19 pandemic – A Malaysian perspectiveCOVID-19 전염병 속에서 국제 여행 및 국경 조치를 위한 위험 계층화 및 평가 프레임워크 - 말레이시아 관점Article Published on 2022-05-012022-09-11 Journal: Travel medicine and infectious disease [Category] 변종, [키워드] Activation biosecurity border control calculate CDC center Control country Country risk stratification COVID-19 COVID-19 pandemic develop disease control fluctuation fluctuations Health Organization incidence incidence of cases International International travel reopening Malaysia measure Measures National outcome pandemic Perspective Planning provide public health reliability risk Risk assessment risk stratification Safe SARS-CoV-2 Stratification Support Surveillance Transmission Travel vaccination variable variant Weighted score. WHO World Health Organization [DOI] 10.1016/j.tmaid.2022.102318 PMC 바로가기 [Article Type] Article
[A new understanding of risk communication in public health emergencies][공중보건 비상상황에서의 위험 커뮤니케이션에 대한 새로운 이해]Review Published on 2022-05-012022-09-11 Journal: Bundesgesundheitsblatt, Gesundheitsforschung, Gesu [Category] COVID19(2023년), SARS, 치료기술, [키워드] addition approach communication crisis crisis communication detection discrepancies discrepancy Emergency English ERC Health health emergency Health Organization Health policy help IHR include international health International health regulation management outbreak pandemic Potential for risk Public public health public health emergency reason response risk Risk communication SARS-CoV‑2 suggested Support Surveillance while WHO World Health Organization [DOI] 10.1007/s00103-022-03529-8 PMC 바로가기 [Article Type] Review
In silico evaluation of Vitis amurensis Rupr. Polyphenol compounds for their inhibition potency against COVID-19 main enzymes Mpro and RdRpReview article Published on 2022-05-012022-10-05 Journal: Saudi Pharmaceutical Journal : SPJ [Category] 신약개발, 치료제, [키워드] anti-viral activity antiviral activities antiviral activity approach approved binding caffeic acid caused Characteristics Chinese Compound compounds COVID-19 COVID-19 disease docking study drug drug candidate drug-likeness drugs enzyme explained ferulic acid FIVE Health Infection Inhibitory effects molecular docking Molecular docking study MPro naringenin novel SARS-CoV-2 virus offer pandemic pharmacokinetic analysis Pneumonia polyphenol polyphenols quercetin RdRP RdRp active site recent Replication reported SARS-CoV-2 the SARS-CoV-2 therapeutic effect Transcription Transmission Treatment Vitis amurensis WHO World Health Organization [DOI] 10.1016/j.jsps.2022.02.014 [Article Type] Review article
Exploratory assessment of serological tests to determine antibody titer against SARS-CoV-2: Appropriateness and limitsSARS-CoV-2에 대한 항체가를 결정하기 위한 혈청학적 검사의 탐색적 평가: 적절성 및 한계Multicenter Study Published on 2022-05-012022-09-11 Journal: Journal of Clinical Laboratory Analysis [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] Analysis analyzed antibody Antibody titer Antibody titers appropriateness can be used Definition detect determine diagnostic diagnostic test diagnostic tests effective Effectiveness Elecsy Elecsys evaluated Health highlight IgA immunoassay Immunoglobulin immunoglobulins Infection International international standard International standards laboratory data limit limitation Luminex xMAP multicenter multiplex Multiplex assay multiplicity RBD resulting Roche S1 domain SARS-CoV-2 SARS-CoV-2 IgG SARS-COV-2 infection SARS-CoV-2 spike protein SARS-CoV-2 test SARS-CoV-2 tests selected serological serological test Serological tests serum serum sample serum samples Siemen Spike protein Standard subject subjects the SARS-CoV-2 the WHO titer to define vaccination Variability WHO [DOI] 10.1002/jcla.24363 PMC 바로가기 [Article Type] Multicenter Study
Clinical Manifestations, Imaging Procedures and Laboratory Parameters among Hospitalized Patients with COVID-19 in Ilam Province, Western Iran이란 서부 일람 주에서 COVID-19로 입원한 환자의 임상 징후, 영상 절차 및 실험실 매개변수Article Published on 2022-05-012022-09-11 Journal: Ethiopian Journal of Health Sciences [Category] COVID19(2023년), SARS, 치료기술, [키워드] addition analyzed bilateral pneumonia Blood Cancer Characteristics clinical Clinical data Clinical symptoms collected Comorbidities Comorbidity confirmed case COPD correlation cough country COVID-19 creatinine dead dead patient dead patients death Deceased demonstrated died discharged Dyspnea electronic medical records epidemiological ESR evaluate evaluated female Ground glass opacity group groups Hospitalized hospitalized COVID-19 identifying Ilam Ilam Province imaging implementation IMPROVE indicated Iran Laboratory Laboratory features Laboratory test Laboratory tests lymphocyte Lymphocyte count male measure medical records medication Middle East neutrophil neutrophil count outcomes pandemic patchy Patient patients patients with COVID-19 pleural effusion Principal component principal component analysis procedure Radiographs radiological regimen RT-PCR SARS-CoV-2 separated significantly more subject Survivors the disease translate treatment regimen treatment regimens two groups underlying disease underlying diseases WBC West WHO with COVID-19 [DOI] 10.4314/ejhs.v32i3.3 PMC 바로가기 [Article Type] Article
Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy항레트로바이러스 요법을 받고 있는 HIV 감염자의 프라임 및 부스트 BNT162b2 백신 접종 후 체액성 면역 반응Article Published on 2022-05-012022-09-12 Journal: HIV medicine [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] acute respiratory syndrome anti-S IgG antibody Antiretroviral therapy ART BNT162b2 boost CD4 CD4 count CD4 T-cell cellular circulating Clinical efficacy Cohort Complete Concentration Control controls coronavirus coronavirus disease coronavirus disease 2019 (COVID-19) vaccination correlated COVID-19 COVID-19 vaccination domain examined Health care worker higher risk HIV HIV-1 HIV-negative humoral immune response Humoral immunity IgG immune response Immune status Immunoglobulin less majority Messenger RNA mounted mRNA mRNA vaccination neutralizing antibody Neutralizing antibody response outcome plasma PLHIV PLWH prime and boost priming produced receiving response RNA robust SARS-CoV-2 severe coronavirus disease significantly higher significantly lower T-cell the SARS-CoV-2 vaccination Variability Viral load WHO with HIV World Health Organization [DOI] 10.1111/hiv.13202 PMC 바로가기 [Article Type] Article